PD-1/PD-L1 axis is the most studied IC pathway in AML (153), and PD-L1 expression on AML blasts were reported to be linked with the inflamed tumor microenvironment, highlighting the potential of targeting BMM in disease management (154, 155). This evidence concerns the gene CD274 and neoplasm.